These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12773918)

  • 1. [Overstimulation of the ovary: prevention and treatment].
    Antoine JM
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S41-5. PubMed ID: 12773918
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro oocyte maturation for safer treatment of infertility. The risk of ovarian overstimulation syndrome is minimized].
    Hreinsson J; Fridström M
    Lakartidningen; 2004 Nov; 101(46):3665-8, 3671. PubMed ID: 15586490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fertilization in the polycystic ovary syndrome patient: an update.
    Lin K; Coutifaris C
    Clin Obstet Gynecol; 2007 Mar; 50(1):268-76. PubMed ID: 17304041
    [No Abstract]   [Full Text] [Related]  

  • 4. Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.
    Huddleston HG; Racowsky C; Jackson KV; Fox JH; Ginsburg ES
    Fertil Steril; 2008 Oct; 90(4):1259-62. PubMed ID: 18163999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
    Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
    Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian hyperstimulation syndrome. Diagnosis and prevention are extremely important].
    Nylund L; Carlström K; Gustafson O
    Lakartidningen; 1993 Mar; 90(10):915-7. PubMed ID: 8459733
    [No Abstract]   [Full Text] [Related]  

  • 7. Less may, indeed, be less: multicollinearity in studies of ovarian reserve.
    Barad DH; Gleicher N
    Fertil Steril; 2009 May; 91(5):e16; author reply e17-8. PubMed ID: 19230879
    [No Abstract]   [Full Text] [Related]  

  • 8. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.
    Selman H; Brusco GF; Fiorini F; Barnocchi N; Mariani M; El-Danasouri I
    Fertil Steril; 2009 Apr; 91(4 Suppl):1611-3. PubMed ID: 19200960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
    Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
    Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
    Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization.
    Delbaere A; Smits G; Vassart G; Costagliola S
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):590-1. PubMed ID: 17082800
    [No Abstract]   [Full Text] [Related]  

  • 14. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
    Fauser BC; Devroey P
    Fertil Steril; 2005 Jun; 83(6):1607-11. PubMed ID: 15950626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of ovarian hyperstimulation syndrome.
    Waterstone J; Bennett S; Ribeiro R; Curson R; Parsons J
    Lancet; 1991 Dec; 338(8781):1536-7. PubMed ID: 1683964
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome.
    Homburg R
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):773-88. PubMed ID: 15380146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S188-93. PubMed ID: 19007627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R; Aboulghar M; Serour G; Amin Y; Abou-Setta AM
    Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.